New chemo timing aims to cut harsh side effects for GI cancer patients
Symptom relief
ENROLLING_BY_INVITATION
This study tests a modified version of standard chemotherapy (capecitabine and oxaliplatin) in 20 people with gastrointestinal cancers. The goal is to see if changing the timing of the drugs reduces side effects like nerve damage, low blood counts, and allergic reactions. Partici…
Phase: PHASE2 • Sponsor: University of Vermont Medical Center • Aim: Symptom relief
Last updated May 01, 2026 14:54 UTC